97059 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for colony-stimulating factors [CSF]
TRANSPLANTING STEM CELL-DERIVED MICROGLIA TO TREAT LEUKODYSTROPHIES
#2METHODS OF TREATING OR PREVENTING A COMPLICATION OF SICKLE CELL DISEASE
#3COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY
#4CAR-EXPRESSING PLURIPOTENT STEM CELL-DERIVED NEUTROPHILS LOADED WITH DRUG NANOPARTICLES AND USES THEREOF
#5ZIP CYTOKINE RECEPTORS
#6TUNABLE CYTOKINE RECEPTOR SIGNALING DOMAINS
#7CHIMERIC CD40 POLYPEPTIDES AND METHODS OF USE IN IMMUNOTHERAPY
#8CONTROLLABLE STIMULATION OF GENETICALLY ENGINEERED LYMPHOCYTES FOR THE TREATMENT OF CANCER
#9METHODS OF TREATING OR PREVENTING A COMPLICATION OF SICKLE CELL DISEASE
#10GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS
#11ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS
#12MODIFIED GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AND CHIMERIC CYTOKINE RECEPTORS BINDING SAME
#13Method for Constructing Murine Model with Mutations in Csf1r Gene and Application thereof
#14SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION
#15COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS
#16Chimeric Cytokine Receptors
#17Modified Extracellular Domain of Granulocyte Colony-Stimulating Factor Receptor (G-CSFG) and Cytokines Binding Same
#18FULLY HUMAN ANTIBODY TARGETING CD5, AND FULLY HUMAN CHIMERIC ANTIGEN RECEPTOR (CAR) AND APPLICATION THEREOF
#19CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS
#20CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME
#21GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS
#22Cells expressing recombinant growth factor receptors
#23GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS
#24COMPOSITIONS AND METHODS FOR USING TRANSPLANTED MICROGLIA AS A VEHICLE FOR WIDESPREAD DELIVERY OF CELLS AND OTHER BIOLOGIC AGENTS TO THE BRAIN
#25COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY
#26Compositions and Methods of Treating Cancer with Chimeric Antigen Receptors Targeting Glypican 3
#27CHIMERIC GMCSF-IL18 RECEPTOR
#28COMPOSITIONS AND METHODS FOR PROMOTING HEMATOPOIETIC CELL CYTOTOXICITY
#29DIMER IMMUNOADHESIN, PHARMACEUTICAL COMPOSTION AND USE THEREOF
#30MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#31Genetically Engineered Cells and Uses Thereof
#32METHODS FOR SCREENING FOR CANCER TARGETS
#33CSF1R-BASED CHIMERIC PROTEINS
#34Cross species single domain antibodies targeting mesothelin for treating solid tumors
#35A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS)
#36CHIMERIC ANTIGEN RECEPTOR T LYMPHOCYTE FOR TREATING TUMORS, PREPARATION METHOD THEREFOR, AND USE THEREOF
#37Chimeric polypeptides and methods of altering the membrane localization of the same
#38Chimeric antigen receptors targeting glypican-3 or mesothelin
#39Compositions and methods of treating cancer with chimeric antigen receptors
#40COMBINATION THERAPIES
#41Methods for screening for cancer targets
#42Chimeric antigen receptors comprising a human transferrin epitope sequence
#43Anti-CD70 chimeric antigen receptors
#44Synthetic biology-based ADCC technology
#45CSF1R-based chimeric proteins
#46CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME
#47CSF1R-CD40L chimeric proteins
#48CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
#49CSF1R-based chimeric proteins
#50IMMUNOMODULATORY IL2R FUSION PROTEINS AND USES THEREOF
#51Engineered antigen presenting cells and uses thereof
#52MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#53Chimeric polypeptides and methods of altering the membrane localization of the same
#54Anti-CD70 chimeric antigen receptors
#55CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
#56MHC-independent tumor-associated antigens
#57Methods and compositions related to modulators of eukaryotic cells
#58CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME
#59Synthetic biology-based ADCC technology
#60Human C-FMS antigen binding proteins
#61Methods and compositions related to modulators of eukaryotic cells
#62T cell receptors with MHC independent binding to GM-CSF receptor alpha chain
#63Anti-mesothelin chimeric antigen receptors
#64Human C-FMS antibodies
#65Cell model and method for screening c-Fms kinase inhibitors
#66Methods for treating conditions associated with c-fms
#67THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF
#68Crystalline composition of GM-CSF/GM-CSFR
#69CSF-1R MUTANTS
#70Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules
#71CSF3R polypeptides and uses thereof
#72Translocation and mutant CSF1R Kinase in human leukemia
#73Human C-FMS antigen binding proteins
#74BIDENTATE MOTIF AND METHODS OF USE
#75Binding motif and methods of regulating cell function
#76Crystal structure of liganded cFMS kinase domain
#77Cell surface receptor isoforms and methods of identifying and using the same
#78Method for transplanting lymphohematopoietic cells into mammal
#79Crystal structure of the c-fms kinase domain: applications and use of heterologous substitutions of kinase insert domains for crystallization
#80Method of treatment and prophylaxis